BIOE

What this means for you

This application is over — abandoned 11 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88577146

Mark type

Stylized text

Filed

13 Aug 2019

Abandoned

11 Jul 2022

Attorney of record

Curtis Wadworth, J.D., Ph.D.

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents for epidermis; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, lipid lowering agents; Balms for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Plant extracts for pharmaceutical purposes

Owner

• Truetiva, Inc., Grand Rapids, MI, US

Prosecution history

• 24 Aug 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 23 Aug 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
• 23 Aug 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 17 Aug 2022 — ASSIGNED TO EXAMINER
• 10 Jan 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 10 Jan 2022 — NON-FINAL ACTION E-MAILED
• 10 Jan 2022 — NON-FINAL ACTION WRITTEN
• 15 Feb 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 15 Feb 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 15 Feb 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 14 Aug 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 14 Aug 2020 — NON-FINAL ACTION E-MAILED
• 14 Aug 2020 — NON-FINAL ACTION WRITTEN
• 06 Aug 2020 — ASSIGNED TO EXAMINER
• 12 Nov 2019 — ASSIGNED TO EXAMINER